Published in Dis Model Mech on May 28, 2015
Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis. Expert Opin Biol Ther (2016) 0.78
A monoclonal natural human IgM protects axons in the absence of remyelination. J Neuroinflammation (2016) 0.75
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study. J Vis Exp (2016) 0.75
Anti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis. Brain (2016) 0.75
From bench to patient: model systems in drug discovery. Dis Model Mech (2015) 0.75
Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis. Sci Rep (2017) 0.75
Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. Biophys J (1976) 25.12
Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci (2004) 6.99
Supported phospholipid bilayers. Biophys J (1985) 6.18
Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci (2010) 4.25
The mechanism of action of cholera toxin in pigeon erythrocyte lysates. J Biol Chem (1975) 4.22
Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler (2008) 4.05
Ultrasmooth patterned metals for plasmonics and metamaterials. Science (2009) 3.43
Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci (2001) 3.11
Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (1995) 2.79
Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog Neurobiol (2008) 2.76
The influence of polyvalency on the binding properties of antibodies. Immunochemistry (1972) 2.67
Surface plasmon sensor based on the enhanced light transmission through arrays of nanoholes in gold films. Langmuir (2004) 2.46
Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc Natl Acad Sci U S A (1996) 2.08
Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A (1999) 1.95
Localized surface plasmon resonance sensing of lipid-membrane-mediated biorecognition events. J Am Chem Soc (2005) 1.89
Fabrication of phospholipid bilayer-coated microchannels for on-chip immunoassays. Anal Chem (2001) 1.69
Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance. Biochemistry (1996) 1.65
Passage of amyloid beta protein antibody across the blood-brain barrier in a mouse model of Alzheimer's disease. Peptides (2002) 1.64
Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther (1991) 1.57
Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron (2013) 1.54
Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A (2002) 1.54
Amyotrophic lateral sclerosis: Problems and prospects. Ann Neurol (2013) 1.53
Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J Neurochem (2010) 1.47
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.46
Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: neuropathology and behavioral deficits in single- and double-null mice. Exp Neurol (2005) 1.32
From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat Genet (2010) 1.32
Template-stripped smooth Ag nanohole arrays with silica shells for surface plasmon resonance biosensing. ACS Nano (2011) 1.29
Axonal protective effects of the myelin-associated glycoprotein. J Neurosci (2009) 1.29
Naturally occurring auto-antibodies in homeostasis and disease. Trends Immunol (2008) 1.28
Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol Pathol (2001) 1.25
Myelin-associated glycoprotein and its axonal receptors. J Neurosci Res (2009) 1.20
A method improving the accuracy of fluorescence recovery after photobleaching analysis. Biophys J (2008) 1.17
Rodent models of amyotrophic lateral sclerosis. Biochim Biophys Acta (2013) 1.17
Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment. Exp Neurol (2007) 1.16
Membrane protein biosensing with plasmonic nanopore arrays and pore-spanning lipid membranes. Chem Sci (2010) 1.14
The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease: a rapid and systematic review. Health Technol Assess (2001) 1.13
A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J (2004) 1.08
Neuron-binding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol (2004) 1.08
Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J (2002) 1.04
Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis. Neurology (1998) 1.03
Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet (2013) 1.03
Exposure levels of anti-LINGO-1 Li81 antibody in the central nervous system and dose-efficacy relationships in rat spinal cord remyelination models after systemic administration. J Pharmacol Exp Ther (2011) 1.02
Time course of neuropathology in the spinal cord of G86R superoxide dismutase transgenic mice. J Comp Neurol (1998) 1.02
Pathogenic and physiological autoantibodies in the central nervous system. Immunol Rev (2012) 1.01
Binding of soluble myelin-associated glycoprotein to specific gangliosides induces the association of p75NTR to lipid rafts and signal transduction. J Neurochem (2005) 0.95
Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations. Br J Pharmacol (2010) 0.95
Gangliosides and the multiscale modulation of membrane structure. Chem Phys Lipids (2011) 0.95
A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination. PLoS One (2011) 0.94
Invited article: human natural autoantibodies in the treatment of neurologic disease. Neurology (2009) 0.93
Arthrobacter ureafaciens sialidase isoenzymes, L, M1 and M2, cleave fucosyl GM1. Glycoconj J (1997) 0.91
Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degeneration. Brain Res Brain Res Rev (1999) 0.90
A human IgM signals axon outgrowth: coupling lipid raft to microtubules. J Neurochem (2011) 0.87
The specificity of monoclonal antibody A2B5 to c-series gangliosides. J Neurochem (2001) 0.87
Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor. Blood (2001) 0.87
Lipid rafts mediate the interaction between myelin-associated glycoprotein (MAG) on myelin and MAG-receptors on neurons. Mol Cell Neurosci (2003) 0.87
Kinetic analysis of antibody-antigen interactions at a supported lipid monolayer. Anal Biochem (1999) 0.87
Enhancing CNS repair in neurological disease: challenges arising from neurodegeneration and rewiring of the network. CNS Drugs (2011) 0.86
Direct observation of myelination in vivo in the mature human central nervous system. A model for the behaviour of oligodendrocyte progenitors and their progeny. Brain (1997) 0.85
Tubulin anchoring to glycolipid-enriched, detergent-resistant domains of the neuronal plasma membrane. J Biol Chem (2000) 0.85
Localization patterns for immunoglobulins and albumins in the brain suggest diverse mechanisms for their transport across the blood-brain barrier (BBB). Prog Brain Res (1992) 0.85
Cellular mechanisms of central nervous system repair by natural autoreactive monoclonal antibodies. Arch Neurol (2009) 0.85
The adhesion protein TAG-1 has a ganglioside environment in the sphingolipid-enriched membrane domains of neuronal cells in culture. J Neurochem (2003) 0.83
High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance. Anal Chem (2012) 0.81
Spinal transection reduces both spinal antinociception and CNS concentration of systemically administered morphine in rats. Brain Res (1991) 0.80
Gangliosides as regulators of cell signaling: ganglioside-protein interactions or ganglioside-driven membrane organization? J Neurochem (2013) 0.77
Atomic layer deposition (ALD): A versatile technique for plasmonics and nanobiotechnology. J Mater Res (2012) 0.76